Circulating endothelial cells in oncology: pitfalls and promises

por Strijbos, M H, Gratama, J W, Kraan, J, Lamers, C H, Bakker, MA den, Sleijfer, S
Publicado 2008

Value of routine daily chest radiography in a non-university ICU: results of a controlled prospective study

por Hendrikse, K, Gratama, J, Hove, W ten, Bendien, K, Rommes, H, Schultz, M, Spronk, P
Publicado 2006

Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells

por Kraan, J, van den Broek, P, Verhoef, C, Grunhagen, D J, Taal, W, Gratama, J W, Sleijfer, S
Publicado 2014

Systematic review of the safety and efficacy of contrast injection via venous catheters for contrast-enhanced computed tomography

por Buijs, S.B., Barentsz, M.W., Smits, M.L.J., Gratama, J.W.C., Spronk, P.E.
Publicado 2017

High prevalence of abdominal aortic aneurysm in older men with cerebrovascular disease: Evaluation of a local screening program

por Loban, M., Gratama, J. W. C., Klemm, P. L., Van Leeuwen, Roeland B., Vriesema, H., Bienfait, Henri Paul
Publicado 2023

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases

por Lalmahomed, Z S, Mostert, B, Onstenk, W, Kraan, J, Ayez, N, Gratama, J W, Grünhagen, D, Verhoef, C, Sleijfer, S
Publicado 2015

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.

por Goey, S. H., Gratama, J. W., Primrose, J. N., Ward, U., Mertelsmann, R. H., Osterwalder, B., Verweij, J., Stoter, G.
Publicado 1996

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.

por Goey, S. H., Eggermont, A. M., Punt, C. J., Slingerland, R., Gratama, J. W., Oosterom, R., Oskam, R., Bolhuis, R. L., Stoter, G.
Publicado 1995

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.

por Kruit, W. H., Punt, C. J., Goey, S. H., de Mulder, P. H., Gratama, J. W., Eggermont, A. M., Bolhuis, R. L., Stoter, G.
Publicado 1996

Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting

por Feller, N, van der Velden, V H J, Brooimans, R A, Boeckx, N, Preijers, F, Kelder, A, de Greef, I, Westra, G, te Marvelde, J G, Aerts, P, Wind, H, Leenders, M, Gratama, J W, Schuurhuis, G J
Publicado 2013

Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomusti...

por Beije, N, Kraan, J, Taal, W, van der Holt, B, Oosterkamp, H M, Walenkamp, A M, Beerepoot, L, Hanse, M, van Linde, M E, Otten, A, Vernhout, R M, de Vos, F Y F, Gratama, J W, Sleijfer, S, van den Bent, M J
Publicado 2015

Addition of FFRct in the diagnostic pathway of patients with stable chest pain to reduce unnecessary invasive coronary angiography (FUSION): Rationale and design for the multicentr...

por Sharma, S. P., Hirsch, A., Hunink, M. G. M., Cramer, M. J. M., Mohamed Hoesein, F. A. A., Geluk, C. A., Kramer, G., Gratama, J. W. C., Braam, R. L., van der Zee, P. M., Yassi, W., Wolters, S. L., Gürlek, C., Pundziute, G., Vliegenthart, R., Budde, R. P. J.
Publicado 2022